Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Study of Efficacy of OXN PR, Compared to Oxy PR, for Reduction of Intensity of Opioid-induced Constipation Symptoms in patients Treated for Cancer or Non-cancer Pain: A Randomised, Double-blind, Controlled, Multicentre Study.

Next Previous
Trial Profile

Study of Efficacy of OXN PR, Compared to Oxy PR, for Reduction of Intensity of Opioid-induced Constipation Symptoms in patients Treated for Cancer or Non-cancer Pain: A Randomised, Double-blind, Controlled, Multicentre Study.

Status: Discontinued
Phase of Trial: Phase III

Latest Information Update: 05 Apr 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Oxycodone/naloxone (Primary) ; Oxycodone
  • Indications Back pain; Cancer pain; Constipation; Musculoskeletal pain; Pain
  • Focus Registrational; Therapeutic Use
  • Sponsors Mundipharma International

    • Most Recent Events

    • 04 Jul 2012 Napp Pharmaceutical Group added as associations as reported in the European Clinical Trials Database record.
    • 15 Nov 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 07 Jun 2011 Planned end date (May 2012) added as reported by ClinicalTrials.gov.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top